These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 26847706)
1. MiR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12. Dong S; Jin M; Li Y; Ren P; Liu J Oncol Rep; 2016 Apr; 35(4):2151-8. PubMed ID: 26847706 [TBL] [Abstract][Full Text] [Related]
2. miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3. Li R; Liu J; Li Q; Chen G; Yu X Tumour Biol; 2016 Mar; 37(3):3987-96. PubMed ID: 26482618 [TBL] [Abstract][Full Text] [Related]
3. miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6. Wen Q; Zhao J; Bai L; Wang T; Zhang H; Ma Q Oncol Rep; 2015 Oct; 34(4):2202-10. PubMed ID: 26239517 [TBL] [Abstract][Full Text] [Related]
4. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2. Xue KC; Hu DD; Zhao L; Li N; Shen HY Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989 [TBL] [Abstract][Full Text] [Related]
5. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4. Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221 [TBL] [Abstract][Full Text] [Related]
6. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway. Ma Y; Qin H; Cui Y Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341 [TBL] [Abstract][Full Text] [Related]
7. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway. Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302 [TBL] [Abstract][Full Text] [Related]
8. MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma. Liu L; Wang J; Li X; Ma J; Shi C; Zhu H; Xi Q; Zhang J; Zhao X; Gu M Biochem Biophys Res Commun; 2015 Feb; 457(4):621-6. PubMed ID: 25603050 [TBL] [Abstract][Full Text] [Related]
9. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features]. Jiang XL; Zhang H; Chen YL; Peng L Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755 [No Abstract] [Full Text] [Related]
10. MicroRNA-101 Targets CXCL12-Mediated Akt and Snail Signaling Pathways to Inhibit Cellular Proliferation and Invasion in Papillary Thyroid Carcinoma. Chen F; Yang D; Ru Y; Cao S; Gao A Oncol Res; 2019 Jun; 27(6):691-701. PubMed ID: 30832753 [TBL] [Abstract][Full Text] [Related]
11. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67. Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway. Zhao J; Li Z; Chen Y; Zhang S; Guo L; Gao B; Jiang Y; Tian W; Hao S; Zhang X Int J Oncol; 2019 Jan; 54(1):315-325. PubMed ID: 30387841 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression. Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471 [TBL] [Abstract][Full Text] [Related]
14. MiR-4500 Regulates PLXNC1 and Inhibits Papillary Thyroid Cancer Progression. Li R; Teng X; Zhu H; Han T; Liu Q Horm Cancer; 2019 Dec; 10(4-6):150-160. PubMed ID: 31317324 [TBL] [Abstract][Full Text] [Related]
15. MiR-128 suppresses the growth of thyroid carcinoma by negatively regulating SPHK1. Cao XZ; Bin H; Zang ZN Biomed Pharmacother; 2019 Jan; 109():1960-1966. PubMed ID: 30551451 [TBL] [Abstract][Full Text] [Related]
16. IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma. Chou CK; Chi SY; Huang CH; Chou FF; Huang CC; Liu RT; Kang HY J Clin Endocrinol Metab; 2016 Nov; 101(11):4357-4366. PubMed ID: 27533309 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma. Wang Z; Zhang H; Zhang P; Dong W; He L Tumour Biol; 2016 Jun; 37(6):7633-44. PubMed ID: 26687649 [TBL] [Abstract][Full Text] [Related]
19. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer. Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells. Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]